In our in silico analysis of gene expression microarrays from both cell lines and patients, elevated cPLA2α mRNA expression was associated with clinical parameters for poor prognosis, which correlate with the HER2-positive and basal-like subtypes of breast cancer. Here, ERBB2 is linked to breast carcinoma.